President & CEO of Synageva BioPharma Corp. (GEVA, Financial) Sanj K Patel sells 50,000 shares of GEVA on 06/04/2012 at an average price of $35.33 a share.
Synageva Biophm has a market cap of $738.1 million; its shares were traded at around $36.35 with and P/S ratio of 351.6.
For the complete insider trading history of GEVA, click here.
Synageva Biophm has a market cap of $738.1 million; its shares were traded at around $36.35 with and P/S ratio of 351.6.
CEO Recent Trades:
- President & CEO Sanj K Patel sold 50,000 shares of GEVA stock on 03/23/2012 at the average price of 33.53. Sanj K Patel owns at least 1,031 shares after this. The price of the stock has increased by 8.41% since.
CFO Recent Trades:
- SVP, CFO Carsten Boess sold 39,709 shares of GEVA stock on 05/16/2012 at the average price of 38.35. The price of the stock has decreased by 5.22% since.
Directors and Officers Recent Trades:
- 10% Owner Daniel R Tisch sold 13,000 shares of GEVA stock on 04/23/2012 at the average price of 39.76. Daniel R Tisch owns at least 448,269 shares after this. The price of the stock has decreased by 8.58% since.
- Director Srinivas Akkaraju sold 342,278 shares of GEVA stock on 03/19/2012 at the average price of 32.55. Srinivas Akkaraju owns at least 1,369,110 shares after this. The price of the stock has increased by 11.67% since.
- 10% Owner Daniel R Tisch sold 7,118 shares of GEVA stock on 02/29/2012 at the average price of 39.1. Daniel R Tisch owns at least 462,731 shares after this. The price of the stock has decreased by 7.03% since.
- Vice President, Finance Chris Heberlig sold 4,500 shares of GEVA stock on 02/27/2012 at the average price of 36.88. The price of the stock has decreased by 1.44% since.
- 10% Owner Daniel R Tisch sold 128,882 shares of GEVA stock on 02/21/2012 at the average price of 36.73. Daniel R Tisch owns at least 518,700 shares after this. The price of the stock has decreased by 1.03% since.
For the complete insider trading history of GEVA, click here.
